Replies to post #124431 on Avid Bioservices Inc (CDMO)

[freethemice]

The ASCO abstract, which stated that a patient discontinued with Bavi, but still remains in the trial
receiving paclitaxel, was written months ago. I do not believe they would "replace" her, it is all part of
the trial to see what safety issues arise, including "infusion related reactions". So when it was announced
on April 29th that the trial had completed enrollment with 14 patients I believe that patient was probably
still enrolled in the trial and receiving paclitaxel.